Professor Ob/Gyn Reproductive Endocrinology
Obstetrics & Gynecology
Dr. Donna Shoupe, MD
|
|
Give Review
Donna Shoupe works in the field of Obstetrics & Gynecology. She studied medicine at The Ohio State University College of Medicine. She received 2 awards: "Super Doctor" and "Fellow (FACOG)". Dr. Donna Shoupe is a published MD. She published 80 publications, including: 'Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets.' Donna Shoupe, MD is registered with Medicare.
Publications
- Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
- Effect of prior oophorectomy on changes in bone mineral density and carotid artery intima-media thickness in postmenopausal women.
- Individualizing hormone-therapy according to cardiovascular risk.
- Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause.
- Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nurses' Health Study.
- Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled tr...
- Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
- Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
- Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.
- Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.
- HRT dosing regimens: continuous versus cyclic-pros and cons.
- Hysterectomy or an alternative?
- Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial.
- Hormone replacement therapy: reassessing the risks and benefits.
- Androgens and bone: clinical implications for menopausal women.
- Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets.
- Contraception in the 1990s.
- Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
- Prevention of vaginal trichomoniasis by compliant use of the female condom.
- Effects of desogestrel on carbohydrate metabolism.
- Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.
- Luteal phase defects.
- New progestins--clinical experiences: gestodene.
- Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
- Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
- Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
- A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol.
- Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women.
- Evidence for altered catecholamine metabolism in polycystic ovary syndrome.
- Priming with gonadotropin-releasing hormone restores gonadotropin secretion during first but not second trimester of pregnancy.
- Prolactin molecular heterogeneity. Response to thyrotropin-releasing hormone stimulation of concanavalin A-bound and -unbound immunoassayable prolactin during human pr...
- The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome.
- Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women.
- The influence of androgens on insulin resistance.
- Insulin resistance in polycystic ovary syndrome.
- The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women.
- Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
- Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography.
- Pregnancy termination with a high and medium dosage regimen of RU 486.
- Pharmacokinetics and metabolism of RU 486.
- Metabolism and serum binding of RU 486 in women after various single doses.
- Termination of early gestation with the anti-progestin steroid RU 486: medium versus low dose.
- Estrogen and progestin effects on urinary calcium and calciotropic hormones in surgically-induced postmenopausal women.
- A randomized comparison of nonoral estradiol delivery in postmenopausal women.
- Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device.
- The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
- Ovulation inhibition with nafarelin acetate nasal administration for six months.
- Dose-related changes in LH bioactivity with intranasal GnRH agonist administration.
- Effects of oral contraceptives on the borderline NIDD patient.
- Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
- Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.
- Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
- Correlation of endometrial maturation with four methods of estimating day of ovulation.
- Norplant: subdermal implant system for long-term contraception.
- Early abortion with a single dose of the antiprogestin RU-486.
- Antiprogestin treatment decreases midluteal luteinizing hormone pulse amplitude and primarily exerts a pituitary inhibition.
- Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective...
- Predictors of failed attempted abortion with the antiprogestin mifepristone (RU 486).
- Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
- Postmenopausal hormone replacement with a combination estrogen-progestin regimen for five days per week.
- Prevention of endometrial hyperplasia in postmenopausal women with intrauterine progesterone.
- Characteristics of ovarian follicular development in Norplant users.
- The significance of bleeding patterns in Norplant implant users.
- Gonadotropin-releasing hormone agonist plus add-back sex steroids to reduce risk of breast cancer.
- Contraceptive options for the gestational diabetic woman.
- GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer.
- Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.
- Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits.
- Effect of bilateral oophorectomy on women''s long-term health.
- Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.
- Elective oophorectomy in the gynecological patient: when is it desirable?
- Ovarian conservation at the time of hysterectomy for benign disease.
- Elective oophorectomy for benign gynecological disorders.
- Unopposed estradiol therapy in postmenopausal women: results from two randomized trials.
- Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
- A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol.
- Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause.
- Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.
- Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer.
Schools
Ohio State University College Of Medicine and Public Health
La Co Usc Med Center
Lac Usc Med Center
Procedures Preformed
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Endometrial Biopsy
- Gynecologic Cancer Screening
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Super Doctor
- Fellow (FACOG)
Education
-
University of Southern California - LAC+USC Medical Center -
The Ohio State University College of Medicine
Hospital
-
California Hospital Medical Center -
Keck Hospital of USC
Drug Facts
| NPI NUMBER | 1356437297 | |
| NPPES Provider LastName | SHOUPE | |
| NPPES Provider FirstName | DONNA | |
| NPPES Provider ZIPCode | 900335310 | |
| NPPES Provider State | CA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 739.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356437297 |
| Last Name Of The Provider | SHOUPE |
| First Name Of The Provider | DONNA |
| View All |
Similar Doctors
|
Dr. Lewis Wyatt Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen L. Durinzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Fassett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ohmar M. Myint, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynelle Murray, MD
This Doctor is OpenDoctor Recommended.
|